Trial
NCT03339336
Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Small Fiber Neuropathy
Intervention
BIIB074
Why stopped
Sponsor decision to close study early; not due to safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-05